Neil S. Horowitz - Concepedia

Author

Neil S. Horowitz

Also Known As

Adam Kibel, Chandrajit P. Raut, Hamilton, Chad A., Horowitz, Neil S., Jill S. Barnholtz-Sloan, John Eckman, Jordonna Fulop, Kristen Shimmel, Michael Muto, N HOROWITZ

394

Publications

42.8K

Citations

H-Index

127

Concepts

All Affiliations

Brigham and Women's Hospital Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital Dana-Farber Brigham Cancer Center

About

Neil S. Horowitz is an author at Brigham and Women's Hospital specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	80	4.8K
2	Public Health	10	10	396
3	Health Sciences	4	4	182
4	Engineering	2	2	984
5	Education	1	1	35

Neil S. Horowitz

126

Publications

8.7K

Citations

H-Index

Page 1

	Year	Citations
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Kyle Ellrott, Matthew H. Bailey, Gordon Saksena, Cell Systems EngineeringGeneticsGenomicsArtifact FilteringTcga Data	2018	895
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids Sarah J. Hill, Brennan Decker, Emma A. Roberts, Cancer Discovery	2018	442
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas Franz X. Schaub, Varsha Dhankani, Ashton C. Berger, Cell Systems	2018	434
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo, Cell	2018	425
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy Joan Montero, Kristopher A. Sarosiek, Joseph D. DeAngelo, Cell MedicineApoptosisPharmacologyCell DeathAnti-cancer Agent	2015	363
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer Ursula A. Matulonis, Suzanne Berlin, Percy Ivy, Journal of Clinical Oncology	2009	300
Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182 Neil S. Horowitz, Austin Miller, Bunja Rungruang, Journal of Clinical Oncology	2015	248
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer Joyce F. Liu, Christina I. Herold, Kathryn P. Gray, JAMA Oncology	2019	218
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer Changxin Wan, Matthew P. Keany, Han Dong, Cancer Research	2020	204
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma Joyce F. Liu, Niya Xiong, Susana M. Campos, Journal of Clinical Oncology	2021	187

Page 1